[HTML] springer.comFull View

[HTML][HTML] Disturbed microbial ecology in Alzheimer's disease: Evidence from the gut microbiota and fecal metabolome

J Xi, D Ding, H Zhu, R Wang, F Su, W Wu, Z Xiao… - BMC microbiology, 2021 - Springer
Background Gut microbiota (GMB) alteration has been reported to influence the Alzheimer's
disease (AD) pathogenesis through immune, endocrine, and metabolic pathways. This study …
被引用次数：55 相关文章
[HTML] nih.gov

[HTML][HTML] Disturbed microbial ecology in Alzheimer's disease: evidence from the gut microbiota and fecal metabolome

J Xi, D Ding, H Zhu, R Wang, F Su, W Wu, Z Xiao… - BMC …, 2021 - ncbi.nlm.nih.gov
Background Gut microbiota (GMB) alteration has been reported to influence the Alzheimer's
disease (AD) pathogenesis through immune, endocrine, and metabolic pathways. This study …

Disturbed microbial ecology in Alzheimer's disease: evidence from the gut microbiota and fecal metabolome

J Xi, D Ding, H Zhu, R Wang, F Su, W Wu, Z Xiao… - 2021 - agris.fao.org
Background Gut microbiota (GMB) alteration has been reported to influence the Alzheimer's
disease (AD) pathogenesis through immune, endocrine, and metabolic pathways. This study …
[HTML] biomedcentral.com

[HTML][HTML] Disturbed microbial ecology in Alzheimer's disease: evidence from the gut microbiota and fecal metabolome

J Xi, D Ding, H Zhu, R Wang, F Su… - BMC …, 2021 - bmcmicrobiol.biomedcentral.com
Gut microbiota (GMB) alteration has been reported to influence the Alzheimer's disease (AD)
pathogenesis through immune, endocrine, and metabolic pathways. This study aims to …

Disturbed microbial ecology in Alzheimer's disease: evidence from the gut microbiota and fecal metabolome.

J Xi, D Ding, H Zhu, R Wang, F Su, W Wu, Z Xiao… - BMC …, 2021 - europepmc.org
Background Gut microbiota (GMB) alteration has been reported to influence the Alzheimer's
disease (AD) pathogenesis through immune, endocrine, and metabolic pathways. This study …

Disturbed microbial ecology in Alzheimer's disease: evidence from the gut microbiota and fecal metabolome.

J Xi, D Ding, H Zhu, R Wang, F Su, W Wu… - BMC …, 2021 - search.ebscohost.com
Background: Gut microbiota (GMB) alteration has been reported to influence the Alzheimer's
disease (AD) pathogenesis through immune, endocrine, and metabolic pathways. This study …

Disturbed microbial ecology in Alzheimer's disease: evidence from the gut microbiota and fecal metabolome

J Xi, D Ding, H Zhu, R Wang, F Su, W Wu… - BMC …, 2021 - search.proquest.com
Background Gut microbiota (GMB) alteration has been reported to influence the Alzheimer's
disease (AD) pathogenesis through immune, endocrine, and metabolic pathways. This study …

Disturbed microbial ecology in Alzheimer's disease: evidence from the gut microbiota and fecal metabolome

J Xi, D Ding, H Zhu, R Wang, F Su, W Wu… - BMC …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Gut microbiota (GMB) alteration has been reported to influence the Alzheimer's
disease (AD) pathogenesis through immune, endocrine, and metabolic pathways. This study …

Disturbed microbial ecology in Alzheimer's disease: evidence from the gut microbiota and fecal metabolome.

J Xi, D Ding, H Zhu, R Wang, F Su, W Wu, Z Xiao… - BMC …, 2021 - go.gale.com
Background Gut microbiota (GMB) alteration has been reported to influence the Alzheimer's
disease (AD) pathogenesis through immune, endocrine, and metabolic pathways. This study …
[PDF] biomedcentral.com

[PDF][PDF] Disturbed microbial ecology in Alzheimer's disease: evidence from the gut microbiota and fecal metabolome

J Xi, D Ding, H Zhu, R Wang, F Su, W Wu, Z Xiao… - 2021 - bmcmicrobiol.biomedcentral.com
Background: Gut microbiota (GMB) alteration has been reported to influence the Alzheimer's
disease (AD) pathogenesis through immune, endocrine, and metabolic pathways. This study …